# Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin

> **NCT01341717** · PHASE4 · COMPLETED · sponsor: **Jothydev's Diabetes and Research Centre** · enrollment: 440 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Glimepiride
- **DRUG:** Metformin
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT01341717
- **Lead sponsor:** Jothydev's Diabetes and Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341717, "Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01341717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*